CEACAM1 distribution and it's effects on angiogenesis and lymphangiogenesis in oral carcinoma

Oral Oncology

Volumn 45, Issue 10, 2009, Pages 883-886

  Zhou, Cheng Jun ^a   Qu, Xun ^b   Yang, Yong Mei ^b   Wang, Fu Fang ^b   Dong, Zuo Qing ^b   Wang, Cheng Qin ^a   Zhang, Xiao Ying ^b   Liu, Gui Xiang ^b   Wei, Feng Cai ^b   Sun, Shan Zhen ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Angiogenesis; CEACAM1; Lymphangiogenesis; Oral carcinoma

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CD31 ANTIGEN; CELL ADHESION MOLECULE; CELL ADHESION MOLECULE 1; LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1; LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANGIOGENESIS; ARTICLE; CANCER SURGERY; CELL DIFFERENTIATION; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; DISEASE SEVERITY; DOUBLE LABELLING IMMUNOFLUORESCENCE; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; TUMOR; TUMOR LOCALIZATION; TUMOR VOLUME;

ANTIGENS, CD; ANTIGENS, CD31; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; ENDOTHELIAL CELLS; FEMALE; HUMANS; LYMPHANGIOGENESIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; VESICULAR TRANSPORT PROTEINS;

EID: 70349137134     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.03.002     Document Type: Article

References (19)

1. Singer B.B., Scheffrahn I., and Obrink B.T. The tumor growth-inhibiting cell adhesion molecule CEACAM1 (C-CAM) is differently expressed in proliferating and quiescent epithelial cells and regulates cell proliferation. Cancer Res 60 (2000) 1236-1244
2. Nakajima A., Iijima H., Neurath M.F., Nagaishi T., Nieuwenhuis E.E., Raychowdhury R., et al. Activation-induced expression of carcinoembryonic antigen-cell adhesion molecule 1 regulates mouse T lymphocyte function. J Immunol 168 (2002) 1028-1035
3. Chen D., Iijima H., Nagaishi T., Nakajima A., Russell S., Raychowdhury R., et al. Carcinoembryonic antigen-related cellular adhesion molecule 1 isforms alternatively inhibit and costimulate human T cell function. J Immunol 172 (2004) 3535-3543
4. Ergun S., Kilic N., Ziegeler G., Hansen A., Nollau P., Gotze J., et al. CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell 5 (2000) 311-320
5. Wagener C., and Ergun S. Angiogenic properties of the carcinoembryonic antigen-related cell adhesion molecule 1. Exp Cell Res 261 (2000) 19-24
6. Kilic N., Oliveira-Ferrer L., Wurmbach J., Loges S., et al. Pro-angiogenic signaling by the endothelial presence of CEACAM1. J Biol Chem 280 3 (2005) 2361-2369
7. Chalajour F., Treede H., Ebrahimnejad A., et al. Angiogenic activation of valvular endothelial cells in aortic valve stenosis. Exp Cell Res 298 (2004) 455-464
8. Oliveira-Ferrer L., Tilki D., Ziegeler G., Hauschild J., Loges S., et al. Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer. Cancer Res 64 (2004) 8932-8938
9. Phan D., Cheng C.J., Galfione M., Vakar-Lopez F., Tunstead J., Thompson N.E., et al. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res 64 (2004) 3072-3078
10. Kammerer R., Riesenberg R., Weiler C., Lohrmann J., Achleypen J., and Zimmermann W. The tumour suppressor gene CEACAM1is completely but reversibly downregulated in renal cell carcinoma. J Pathol 204 (2004) 258-267
11. Laack E., Nikbakht H., Petera A., Kugler C., Jasiewicz Y., et al. Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance. J Clin Oncol 20 (2002) 4279-4284
12. Kilic N., Oliveira-Ferrer L., Neshat-Vahid S., Irmak S., Obst-Pernberg K., et al. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. Blood 110 (2007) 4223-4233
13. Barnes H., Eveson J.W., Reichart P., and Sidransky D. WHO: pathology and genetics, head and neck tumours: tumours of the oral cavity and oropharynx (2005), IARC Press, Lyon p. 163-208
14. Banerji S., Ni J., Wang S.W., et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J cell Biol 144 (1999) 789-801
15. Sienel W., Dango S., Woelfle U., Morresi-Hauf A., Wagener C., Brummer J., et al. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 promotes progression of non-small cell lung cancer. Clin Cancer Res 9 (2003) 2260-2266
16. Trojan L., Michel M.S., Rensch F., et al. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1). J Urol 172 1 (2004) 103-107
17. Mario M., Muller, Bernhard B., Singer, Esther K., et al. Transmembrane CEACAM1 affects integrin-dependent signaling and regulates extracellular matrix protein-specific morphology and migration of endothelial cells. Blood 105 (2005) 3925-3934
18. Tilki D., Irmak S., Oliveira-Ferrer L., et al. CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. Oncogene 25 (2006) 4965-4974
19. Volpert O., Luo W., Liu T.-Jen., Vicky T., et al. Inhibition of prostate tumor angiogenesis by the tumor suppressor CEACAM1. J Biol Chem 277 38 (2002) 35696-35702